Alpha-crystallin acting as a molecular chaperone protects catalase against steroid-induced inactivation

FEBS Letters

Volumn 382, Issue 3, 1996, Pages 281-284

  Hook, Darren W A ^a   Harding, John J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Catalase; Chaperone; Prednisolone 21 hemisuccinate; Steroid induced cataract; Crystallin

Indexed keywords

ALPHA CRYSTALLIN; BOVINE SERUM ALBUMIN; CATALASE; CHAPERONE; CHYMOTRYPSINOGEN; GLUCOSE OXIDASE; HUMAN ALBUMIN; LYSOZYME; PREDNISOLONE HEMISUCCINATE; RIBONUCLEASE;

ANIMAL TISSUE; ARTICLE; CATARACT; CATTLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; ENZYME INACTIVATION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; LIVER; NONHUMAN; PRIORITY JOURNAL;

EID: 0029878451     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-5793(96)00134-2     Document Type: Article

References (32)

1. Percy, M.E. (1984) Can. J. Biochem. Cell Biol. 62, 1006-1014.
2. Hockwin, O. and Ohrloff, C. (1981) in: Molecular and Cellular Biology of the Eye (Bloemendal, H. ed.) pp. 367-413, Wiley, New York.
3. Harding, J.J. and Crabbe, M.J.C. (1984) in: The Eye, vol. IB (Davson, H. ed.) pp. 207-492, Academic Press, London.
4. Black, R.L., Oglesby, R.B., Von Sallmann, L. and Bunim, J.J. (1960) J. Am. Med. Assoc. 177, 166-171.
5. Harding, J.J. and Van Heyningen, R. (1988) Br. J. Ophthalmol. 72, 809-814.
6. Italian-American Cataract Study Group (1991) Am. J. Epidemiol. 133, 541-553.
7. Leske, M.C., Chylack, Jr., L.T. and Wu, S.-Y. (1991) Arch. Ophthalmol. 109, 244-251.
8. Bucala, R., Gallati, M., Manabe, S., Cotlier, E. and Cerami, A. (1985) Exp. Eye Res. 40, 853-863.
9. Nishigori, H., Lee, J.W., Yamauchi, Y., Maruyama, K. and Iwatsuru, M. (1987) Invest. Ophthalmol. Vis. Sci. 28, 168-174.
10. Manabe, S., Bucala, R. and Cerami, A. (1984) J. Clin. Invest. 74, 1803-1810.
11. Murphy, M.R.N., Reid, T.J., Sicignano, A., Tanaka, N. and Rossmann, M.G. (1981) J. Mol. Biol. 152, 465-499.
12. Ingolia, T.D. and Craig, E.A. (1982) Proc. Natl. Acad. Sci. USA 79, 2360-2364.
13. Merck, K.B., Groenen, P.J.T.A., Voorter, C.E.M., de Haard-Hoekman, W.A., Horwitz, J., Bloemendal, H. and De Jong, W.W. (1993) J. Biol. Chem. 268, 1046-1052.
14. Horwitz, J. (1992) Proc. Natl. Acad. Sci. USA 89, 2360-2364.
15. Bhat, S.P. and Nagineni, C.N. (1989) Biochem. Biophys. Res. Commun. 158, 319-325.
16. Aoyama, A., Steiger, R.H., Frohli, E., Schafer, R., Von Deimling, A., Wiestler, O.D. and Klemenz, R. (1993) Int. J. Cancer. 55, 760-764.
17. Deretic, D., Aebersold, R.H., Morrison, H.D. and Papermaster, D.S. (1994) J. Biol. Chem. 269, 24, 16853-16861.
18. Van Noort, J.M., Van Sechel, A.C., Bajramovic, J.J., El Ouagmori, M., Polman, C.H., Lassmann, H. and Ravid, R. (1995) Nature 375, 798-801 and 739-740.
19. Ganea, E. and Harding, J.J. (1995) Eur. J. Biochem. 231, 181-185.
20. Tardieu, A., Laporte, D., Licinio, P., Krop, B. and Delaye, M. (1986) Modern Trends in Ageing Research, Colloque INSERM 147, pp. 271-277, EURAGE/John Libbey Eurotext.
21. Augusteyn, R.C. and Koretz, J.F. (1987) FEBS Lett. 222, 1-5.
22. Wistow, G. (1993) Exp. Eye Res. 56, 729-732.
23. Carver, J.A., Aquilina, J.A. and Truscott, R.J.W. (1994) Exp. Eye Res. 59, 231-234.
24. Swamy, M.S. and Abraham, E.G. (1989) Invest. Ophthalmol. Vis. Sci. 30, 1120-1126.
25. Blakytny, R. and Harding, J.J. (1992) Exp. Eye Res. 54, 509-518.
26. Cotlier, E. and Sharma, Y.G. (1981) Lancet, i, 338-341.
27. Harding, J.J., Egerton, M. and Harding, R.S. (1989) Acta Ophthalmol. 67, 518-524.
28. Harding, J.J. (1991) Cataract. Biochemistry, Epidemiology and Pharmacology, Chapman & Hall, London, pp. 233-235.
29. Slingsby, C. and Bateman, O.A. (1990) Exp. Eye Res. 51, 21-26.
30. Van den Oetelaar, P.J.M., Clauwaert, J., Van Laethem, M. and Hoenders, H.J. (1985) J. Biol. Chem. 260, 14030-14034.
31. Beswick, H.T. and Harding, J.J. (1987) Biochem. J. 246, 761-769.
32. Liang, J.N. and Chylack, L.T. (1987) Invest. Ophthalmol. Vis. Sci. 28, 790-794.